Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Società Italiana di Allergologia e Immunologia Clinica

Translated title of the contribution: Italian Society of Allergy and Clinical Immunology guidelines for the diagnosis and treatment of Common Variable Immunodeficiency (CVID)

Fernando Aiuti, A. Aiuti, L. Calza, F. Chiodo, W. De Santis, G. D'Ettorre, L. Emmi, A. Isgrò, G. Luzi, E. Maggi, M. Marziali, I. Mezzaroma, M. Montroni, M. Muscaritoli, R. Paganelli, F. Pandolfi, S. Starnino, M. C. Sirianni, G. Spadaro, V. Vullo

Research output: Contribution to journalArticle

Abstract

The Study Group was established by the Italian Society of Allergy and Clinical Immunology for the preparation of guidelines regarding various forms of primitive immunodeficiency. In this study such guidelines are reported for the diagnosis and therapy of Common Variable Immunodeficiency (CVID), according to a group of experts composed of clinical immunologists, infective disease specialists, nutritionists, molecular biologists and gene therapists. CVID represents a heterogenous group of various symptoms which generally manifest themselves in adolescence or in adulthood. Symptoms include recurrent respiratory and gastroenteric infections which if not treated early on can lead to chronic respiratory or gastroenteric insufficiency, bronchiectasis, chronic diarrhoea and malnutrition. In a part of subjects, autoimmune diseases can develop such as idiopathic trombocytopenic purpura, autoimmune haemolytic anemia, gastroenteric neoplasia or lymphoma. 10% of subjects will also face a chronic disease such as non caseosis granulomatosis of lymphnodes or spleen. In only 5% of patients a molecular genetic defect has been found, related mainly to the absence or severe defect of regolatory molecules of immune response in B or T cells. A severe diminution of Ig classes or subclasses is relevant for the diagnosis. In addition a defect of CD4 cells has been recently reported in almost 50% of patients. The diminution of naive T cells is present mainly in CVID patients with severe recurrent infection. The authors prepared guidelines for both the prophylaxis and therapy of infections as well as the correct substitution therapy with i.v. IgG. In addition, social and psychological assistance factors are reported since they are crucial in the correct clinical maintenance of patients. Prospects for the future are also mentioned concerning the improvement of molecular diagnosis and identification of new therapeutic strategies.

Original languageItalian
Pages (from-to)1-30
Number of pages30
JournalItalian Journal of Allergy and Clinical Immunology
Volume16
Issue numberSUPPL. 1
Publication statusPublished - Mar 2006

Fingerprint

Common Variable Immunodeficiency
Allergy and Immunology
Guidelines
T-Lymphocytes
Autoimmune Hemolytic Anemia
Purpura
Bronchiectasis
Nutritionists
Therapeutics
Infection
Malnutrition
Respiratory Tract Infections
Autoimmune Diseases
Molecular Biology
Diarrhea
Lymphoma
B-Lymphocytes
Chronic Disease
Spleen
Immunoglobulin G

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Società Italiana di Allergologia e Immunologia Clinica. / Aiuti, Fernando; Aiuti, A.; Calza, L.; Chiodo, F.; De Santis, W.; D'Ettorre, G.; Emmi, L.; Isgrò, A.; Luzi, G.; Maggi, E.; Marziali, M.; Mezzaroma, I.; Montroni, M.; Muscaritoli, M.; Paganelli, R.; Pandolfi, F.; Starnino, S.; Sirianni, M. C.; Spadaro, G.; Vullo, V.

In: Italian Journal of Allergy and Clinical Immunology, Vol. 16, No. SUPPL. 1, 03.2006, p. 1-30.

Research output: Contribution to journalArticle

Aiuti, F, Aiuti, A, Calza, L, Chiodo, F, De Santis, W, D'Ettorre, G, Emmi, L, Isgrò, A, Luzi, G, Maggi, E, Marziali, M, Mezzaroma, I, Montroni, M, Muscaritoli, M, Paganelli, R, Pandolfi, F, Starnino, S, Sirianni, MC, Spadaro, G & Vullo, V 2006, 'Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Società Italiana di Allergologia e Immunologia Clinica', Italian Journal of Allergy and Clinical Immunology, vol. 16, no. SUPPL. 1, pp. 1-30.
Aiuti, Fernando ; Aiuti, A. ; Calza, L. ; Chiodo, F. ; De Santis, W. ; D'Ettorre, G. ; Emmi, L. ; Isgrò, A. ; Luzi, G. ; Maggi, E. ; Marziali, M. ; Mezzaroma, I. ; Montroni, M. ; Muscaritoli, M. ; Paganelli, R. ; Pandolfi, F. ; Starnino, S. ; Sirianni, M. C. ; Spadaro, G. ; Vullo, V. / Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Società Italiana di Allergologia e Immunologia Clinica. In: Italian Journal of Allergy and Clinical Immunology. 2006 ; Vol. 16, No. SUPPL. 1. pp. 1-30.
@article{ecaec9bb8dbc437d98d59dacbaf13bdc,
title = "Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Societ{\`a} Italiana di Allergologia e Immunologia Clinica",
abstract = "The Study Group was established by the Italian Society of Allergy and Clinical Immunology for the preparation of guidelines regarding various forms of primitive immunodeficiency. In this study such guidelines are reported for the diagnosis and therapy of Common Variable Immunodeficiency (CVID), according to a group of experts composed of clinical immunologists, infective disease specialists, nutritionists, molecular biologists and gene therapists. CVID represents a heterogenous group of various symptoms which generally manifest themselves in adolescence or in adulthood. Symptoms include recurrent respiratory and gastroenteric infections which if not treated early on can lead to chronic respiratory or gastroenteric insufficiency, bronchiectasis, chronic diarrhoea and malnutrition. In a part of subjects, autoimmune diseases can develop such as idiopathic trombocytopenic purpura, autoimmune haemolytic anemia, gastroenteric neoplasia or lymphoma. 10{\%} of subjects will also face a chronic disease such as non caseosis granulomatosis of lymphnodes or spleen. In only 5{\%} of patients a molecular genetic defect has been found, related mainly to the absence or severe defect of regolatory molecules of immune response in B or T cells. A severe diminution of Ig classes or subclasses is relevant for the diagnosis. In addition a defect of CD4 cells has been recently reported in almost 50{\%} of patients. The diminution of naive T cells is present mainly in CVID patients with severe recurrent infection. The authors prepared guidelines for both the prophylaxis and therapy of infections as well as the correct substitution therapy with i.v. IgG. In addition, social and psychological assistance factors are reported since they are crucial in the correct clinical maintenance of patients. Prospects for the future are also mentioned concerning the improvement of molecular diagnosis and identification of new therapeutic strategies.",
keywords = "Diagnosis, Guidelines, Immunodeficiency, Immunoglobulins, Therapy",
author = "Fernando Aiuti and A. Aiuti and L. Calza and F. Chiodo and {De Santis}, W. and G. D'Ettorre and L. Emmi and A. Isgr{\`o} and G. Luzi and E. Maggi and M. Marziali and I. Mezzaroma and M. Montroni and M. Muscaritoli and R. Paganelli and F. Pandolfi and S. Starnino and Sirianni, {M. C.} and G. Spadaro and V. Vullo",
year = "2006",
month = "3",
language = "Italian",
volume = "16",
pages = "1--30",
journal = "Italian Journal of Allergy and Clinical Immunology",
issn = "1120-6373",
publisher = "Italian Society of Allergy and Clinical Immunology",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV). Documento a cura della Società Italiana di Allergologia e Immunologia Clinica

AU - Aiuti, Fernando

AU - Aiuti, A.

AU - Calza, L.

AU - Chiodo, F.

AU - De Santis, W.

AU - D'Ettorre, G.

AU - Emmi, L.

AU - Isgrò, A.

AU - Luzi, G.

AU - Maggi, E.

AU - Marziali, M.

AU - Mezzaroma, I.

AU - Montroni, M.

AU - Muscaritoli, M.

AU - Paganelli, R.

AU - Pandolfi, F.

AU - Starnino, S.

AU - Sirianni, M. C.

AU - Spadaro, G.

AU - Vullo, V.

PY - 2006/3

Y1 - 2006/3

N2 - The Study Group was established by the Italian Society of Allergy and Clinical Immunology for the preparation of guidelines regarding various forms of primitive immunodeficiency. In this study such guidelines are reported for the diagnosis and therapy of Common Variable Immunodeficiency (CVID), according to a group of experts composed of clinical immunologists, infective disease specialists, nutritionists, molecular biologists and gene therapists. CVID represents a heterogenous group of various symptoms which generally manifest themselves in adolescence or in adulthood. Symptoms include recurrent respiratory and gastroenteric infections which if not treated early on can lead to chronic respiratory or gastroenteric insufficiency, bronchiectasis, chronic diarrhoea and malnutrition. In a part of subjects, autoimmune diseases can develop such as idiopathic trombocytopenic purpura, autoimmune haemolytic anemia, gastroenteric neoplasia or lymphoma. 10% of subjects will also face a chronic disease such as non caseosis granulomatosis of lymphnodes or spleen. In only 5% of patients a molecular genetic defect has been found, related mainly to the absence or severe defect of regolatory molecules of immune response in B or T cells. A severe diminution of Ig classes or subclasses is relevant for the diagnosis. In addition a defect of CD4 cells has been recently reported in almost 50% of patients. The diminution of naive T cells is present mainly in CVID patients with severe recurrent infection. The authors prepared guidelines for both the prophylaxis and therapy of infections as well as the correct substitution therapy with i.v. IgG. In addition, social and psychological assistance factors are reported since they are crucial in the correct clinical maintenance of patients. Prospects for the future are also mentioned concerning the improvement of molecular diagnosis and identification of new therapeutic strategies.

AB - The Study Group was established by the Italian Society of Allergy and Clinical Immunology for the preparation of guidelines regarding various forms of primitive immunodeficiency. In this study such guidelines are reported for the diagnosis and therapy of Common Variable Immunodeficiency (CVID), according to a group of experts composed of clinical immunologists, infective disease specialists, nutritionists, molecular biologists and gene therapists. CVID represents a heterogenous group of various symptoms which generally manifest themselves in adolescence or in adulthood. Symptoms include recurrent respiratory and gastroenteric infections which if not treated early on can lead to chronic respiratory or gastroenteric insufficiency, bronchiectasis, chronic diarrhoea and malnutrition. In a part of subjects, autoimmune diseases can develop such as idiopathic trombocytopenic purpura, autoimmune haemolytic anemia, gastroenteric neoplasia or lymphoma. 10% of subjects will also face a chronic disease such as non caseosis granulomatosis of lymphnodes or spleen. In only 5% of patients a molecular genetic defect has been found, related mainly to the absence or severe defect of regolatory molecules of immune response in B or T cells. A severe diminution of Ig classes or subclasses is relevant for the diagnosis. In addition a defect of CD4 cells has been recently reported in almost 50% of patients. The diminution of naive T cells is present mainly in CVID patients with severe recurrent infection. The authors prepared guidelines for both the prophylaxis and therapy of infections as well as the correct substitution therapy with i.v. IgG. In addition, social and psychological assistance factors are reported since they are crucial in the correct clinical maintenance of patients. Prospects for the future are also mentioned concerning the improvement of molecular diagnosis and identification of new therapeutic strategies.

KW - Diagnosis

KW - Guidelines

KW - Immunodeficiency

KW - Immunoglobulins

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33745184888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745184888&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33745184888

VL - 16

SP - 1

EP - 30

JO - Italian Journal of Allergy and Clinical Immunology

JF - Italian Journal of Allergy and Clinical Immunology

SN - 1120-6373

IS - SUPPL. 1

ER -